What is griseofulvin (antifungal medication) used for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Griseofulvin Tablet Indications

Griseofulvin is primarily indicated for the treatment of dermatophyte infections of the skin, hair, and nails that cannot be adequately treated with topical therapy. 1

Specific Indications

Griseofulvin is FDA-approved for the following dermatophyte infections:

  • Tinea capitis (ringworm of the scalp)
  • Tinea corporis (ringworm of the body)
  • Tinea pedis (athlete's foot)
  • Tinea cruris (jock itch)
  • Tinea barbae (ringworm of the beard)
  • Tinea unguium (onychomycosis/nail infections) 1

These infections must be caused by susceptible dermatophyte species including:

  • Epidermophyton floccosum
  • Microsporum species (audouinii, canis, gypseum)
  • Trichophyton species (crateriform, gallinae, interdigitalis, megnini, mentagrophytes, rubrum, schoenleini, sulphureum, tonsurans, verrucosum) 1

Mechanism of Action

Griseofulvin is fungistatic and works by:

  • Binding to microtubular proteins required for fungal cell mitosis
  • Inhibiting nucleic acid synthesis
  • Arresting cell division at metaphase
  • Impairing cell wall synthesis 2, 1

Clinical Applications and Efficacy

Tinea Capitis

  • Considered the treatment of choice for tinea capitis, particularly for Microsporum infections 2
  • Standard treatment protocol: 20 mg/kg daily for 6-8 weeks in children weighing <50 kg 2
  • Higher efficacy against Microsporum species (88.5%) compared to Trichophyton species (67.9%) 2

Onychomycosis

  • While historically used for nail infections, griseofulvin has been largely superseded by newer antifungals due to:
    • Long treatment duration (6-18 months)
    • Lower efficacy rates (approximately 30%)
    • High relapse rates 2, 3

Important Considerations

Administration

  • Should be taken with fatty food to increase absorption and improve bioavailability 2, 4
  • Prior to initiating treatment, appropriate laboratory testing (KOH preparation, fungal culture, or nail biopsy) should confirm the diagnosis 1

Contraindications

  • Not effective for bacterial infections, candidiasis, or other fungal infections not caused by dermatophytes 1
  • Contraindicated in lupus erythematosus, porphyria, and severe liver disease 5
  • Contraindicated in pregnancy 5
  • Men should avoid fathering a child for 6 months after therapy 5

Side Effects

  • Generally well-tolerated, especially in children 4
  • Common side effects (8-15% of patients) include:
    • Gastrointestinal disturbances
    • Headaches
    • Skin rashes 5, 4

Drug Interactions

  • May interact with:
    • Warfarin
    • Cyclosporine
    • Oral contraceptives (may reduce effectiveness)
    • Barbiturates 5, 4

Current Treatment Landscape

While griseofulvin has been used for over 40 years, newer antifungal agents like terbinafine, itraconazole, and fluconazole are now often preferred for many fungal infections due to:

  • Shorter treatment durations
  • Better efficacy profiles, particularly for Trichophyton infections
  • Lower relapse rates 2, 3

However, griseofulvin remains valuable for:

  • Pediatric patients with tinea capitis, particularly Microsporum infections 2, 6
  • Patients who cannot tolerate or have contraindications to newer antifungals
  • Cases where it is the only licensed option available 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral therapeutic agents in fungal nail disease.

Journal of the American Academy of Dermatology, 1994

Research

[Griseofulvin].

Annales de dermatologie et de venereologie, 2001

Guideline

Griseofulvin Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of tinea capitis - a critical appraisal.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.